Comment on : T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment : a prospective pilot study

Comment on : T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment : a prospective pilot study / P.L. White, R.A. Barnes, R. Gorton, M. Cruciani, J. Loeffler, A. Alanio, R. Bialek, S. Bretagne, D. Buchheidt, M.J.B. Serna, A. Caliendo, S. Chen, N. Clancy, M. Cogliati, C. Cordonnier, B. Crowley, J.P. Donnelly, M. Guiver, F. Hagen, C. Halliday, P. Hamal, W. Heinz, K. Jaton, E. Johnson, B. Jones, L. Klingspor, R.K. Hare, M. Lackner, K. Lagrou, F. Lamoth, M. Lengerova, C. Linton, D. Lockhart, J. Loeffler, J. Maertens, W. Melchers, C. Mengoli, L. Millon, O. Morton, M.H. Nguyen, L. Novak-Frazer, M. Paholcsek, T. Patterson, W. Posch, R. Richardson, V. Rickerts, T. Rogers, M. Ruhnke, B. Sendid, E. Snelders, T.A. Vyzantiadis, P. Warn, A. Warris, B. Weinbergerova, B. Willinger. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 74:2(2019 Feb 01), pp. 532-533. [10.1093/jac/dky325]